COGT earnings: real EPS beat/miss history, analyst consensus Buy, P/E -12.84. Updated 2026-07-23.
Cogent Biosciences (COGT) Research Hub
Cogent Biosciences (COGT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 33.41 USD (-2.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -12.84, market cap 6.63B. This hub links to the full technical, earnings and options research available for COGT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 33.41 USD (-2.25%) |
| 52-week range | 32.95 USD – 43.39 USD |
| Trend regime | Range |
| 14-day RSI | 12.1 (Oversold) |
| Trailing P/E | -12.84 |
| Market cap | 6.63B |
| Dividend yield | 0.00% |
Available research for COGT
Covered Call on COGT: how it works, illustrative setup around the real 33.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on COGT: how it works, illustrative setup around the real 33.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on COGT: how it works, illustrative setup around the real 33.41 USD price, max profit/loss, breakeven and when to use it. Educational.
COGT technical analysis: range, last 33.41 USD, RSI 12.1, 52w range 32.95 USD–43.39 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is COGT in?
Cogent Biosciences (COGT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is COGT in an uptrend or downtrend?
As of 2026-09-11, COGT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is COGT's trailing P/E ratio?
COGT's trailing P/E is -12.84, with a market cap of 6.63B. See the earnings research page for full valuation detail.